下一代PDK1调节器的合理设计:通过分子洞察力解决选择性和抗性 - - 药物化学视角
Yuxing Fu1, Yuxuan Zhu1, Xin Zhou1
1Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, 605 Fenglin Road, Nanchang, Jiangxi, 330013, China.
Bioorganic chemistry
|November 21, 2025
概括
3-酸依赖蛋白激酶1 (PDK1) 是细胞功能的关键调节剂,其失调与癌症等疾病有关. 本综述探讨了PDK1调节器,重点关注开发有效治疗方法的挑战和机会.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 3-酸依赖蛋白激酶1 (PDK1) 是一个关键的信号枢纽,与细胞增殖,新陈代谢和生存有关.
- 失调的PDK1活性与癌症,代谢障碍和神经退行性疾病有关,使PDK1调节器成为一个重要的研究领域.
- 之前的ATP竞争性抑制剂面临的局限性包括非目标效应和薄膜透性.
研究的目的:
- 提供一个系统的概述,3-酸依赖蛋白激酶1 (PDK1) 调节器的发展.
- 根据它们的作用机制和结合方式对PDK1调节器进行分类,包括全结合剂,ATP竞争性抑制剂和DFG-out合规诱导剂.
- 分析结构-活动关系 (SAR),生物活动和作用机制,同时突出挑战和机遇.
主要方法:
- 对PDK1调节器的文献进行系统审查.
- 基于作用机制和结合方式 (全性,ATP竞争性,DFG-out) 的调节器的分类.
- 结构-活动关系 (SAR) 和生物活动的分析.
主要成果:
- 通过基于结构的药物设计来识别新型化学型.
- 发现了针对PDK1和调节PDK1/Akt/mTOR通路的天然产品.
- 认可持续存在的挑战,如选择性不足,药物类属性低于最佳,以及治疗耐药性.
结论:
- 自然产品的结构多样性为设计下一代PDK1抑制剂提供了潜力,其选择性得到改善,毒性降低.
- 解决选择性,类似药物的特性和耐药性的挑战对于治疗进步至关重要.
- 本综述为开发新型PDK1向疗法提供了框架,这些疗法具有增强的疗效和安全性.
相关概念视频
01:28Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
222
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
222
01:26Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
01:24Principles of Drug Action
7.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
7.9K
01:25Dose-Response Relationship: Selectivity and Specificity
9.5K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.5K
01:26Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K